- Statement of Changes in Beneficial Ownership (4)
April 28 2010 - 3:40PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Expires:
February 28, 2011
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
MPM BIOVENTURES II QP LP
|
2. Issuer Name
and
Ticker or Trading Symbol
SENORX INC
[
SENO
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
__
X
__ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
C/O MPM ASSET MANAGEMENT, 200 CLARENDON STREET, 54TH FLOOR
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
4/26/2010
|
(Street)
BOSTON, MA 02116
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_
X
_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
4/26/2010
|
|
S
|
|
1000
(1)
|
D
|
$10.05
|
2207668
|
I
|
See footnote
(2)
|
Common Stock
|
4/27/2010
|
|
S
|
|
13900
(3)
|
D
|
$10.09
|
2193768
|
I
|
See footnote
(4)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
(
1)
|
The shares were sold as follows: 674 by MPM BioVentures II-QP, L.P. ("BV II QP"), 75 by MPM BioVentures II, L.P. ("BV II"), 14 by MPM Asset Management Investors 2001 LLC ("AM 2001") and 237 by MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG ("BV KG"). MPM Asset Management II, L.P. ("AM II GP") and MPM Asset Management II LLC ("AM II LLC") are the direct and indirect general partners of BV II QP, BV II and BV KG. Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Michael Steinmetz and Kurt Wheeler are the members of AM II LLC and AM 2001.
|
(
2)
|
The shares are held as follows: 1,488,412 by BV II QP, 164,250 by BV II, 30,906 by AM 2001 and 524,100 by BV KG. Each member of the group disclaims beneficial ownership of the securities except to the extent of his or its pecuniary interest therein.
|
(
3)
|
The shares were sold as follows: 9,371 by BV II QP, 1,034 by BV II, 195 by AM 2001 and 3,300 by BV KG.
|
(
4)
|
The shares are held as follows: 1,479,041 by BV II QP, 163,216 by BV II, 30,711 by AM 2001 and 520,800 by BV KG. Each member of the group disclaims beneficial ownership of the securities except to the extent of his or its pecuniary interest therein.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
MPM BIOVENTURES II QP LP
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON, MA 02116
|
|
X
|
|
|
MPM BIOVENTURES II LP
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON, MA 02116
|
|
X
|
|
|
MPM BIOVENTURES GMBH & CO PARALLEL BETEILIGUNGS KG
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON, MA 02116
|
|
X
|
|
|
MPM ASSET MANAGEMENT INVESTORS 2001 LLC
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON, MA 02116
|
|
X
|
|
|
MPM ASSET MANAGEMENT II LP
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON, MA 02116
|
|
X
|
|
|
MPM ASSET MANAGEMENT II LLC
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON, MA 02116
|
|
X
|
|
|
GADICKE ANSBERT
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON, MA 02116
|
|
X
|
|
|
STEINMETZ MICHAEL
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON, MA 02116
|
|
X
|
|
|
EVNIN LUKE
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON, MA 02116
|
|
X
|
|
|
GALAKATOS NICHOLAS
C/O MPM ASSET MANAGEMENT
200 CLARENDON STREET, 54TH FLOOR
BOSTON, MA 02116
|
|
X
|
|
|
Signatures
|
By Luke Evnin, manager of MPM Asset Management II LLC, the general partner of MPM Asset Management II, L.P., the general partner of MPM BioVentures II-QP, L.P /s/ Luke Evnin
|
|
4/28/2010
|
**
Signature of Reporting Person
|
Date
|
By Luke Evnin, manager of MPM Asset Management II LLC, the general partner of MPM Asset Management II, L.P.,the general partner of MPM BioVentures II, L.P /s/ Luke Evnin
|
|
4/28/2010
|
**
Signature of Reporting Person
|
Date
|
By Luke Evnin, manager of MPM Asset Management II LLC, the general partner of MPM Asset Management II, L.P.,the special limited partner of MPM BioVentures GmbH and Co. Parallel-Beteiligungs KG /s/ Luke Evnin
|
|
4/28/2010
|
**
Signature of Reporting Person
|
Date
|
By Luke Evnin, manager of MPM Asset Management Investors 2001 LLC /s/ Luke Evnin
|
|
4/28/2010
|
**
Signature of Reporting Person
|
Date
|
By Luke Evnin, manager of MPM Asset Management II LLC, the general partner of MPM Asset Management II, L.P. /s/ Luke Evnin
|
|
4/28/2010
|
**
Signature of Reporting Person
|
Date
|
By Luke Evnin, investment manager of MPM Asset Managment II, LLC /s/ Luke Evnin
|
|
4/28/2010
|
**
Signature of Reporting Person
|
Date
|
/s/ Ansbert Gadicke
|
|
4/28/2010
|
**
Signature of Reporting Person
|
Date
|
/s/ Michael Steinmetz
|
|
4/28/2010
|
**
Signature of Reporting Person
|
Date
|
/s/ Luke Evnin
|
|
4/28/2010
|
**
Signature of Reporting Person
|
Date
|
/s/ Nicholas Galakatos
|
|
4/28/2010
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Senorx (MM) (NASDAQ:SENO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Senorx (MM) (NASDAQ:SENO)
Historical Stock Chart
From Jul 2023 to Jul 2024